EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MDD: RESULTS FROM 8 PLACEBO-CONTROLLED STUDIES

被引：0
|
作者：
Montgomery, S. [1 ]
Kalali, A. [2 ,3 ]
Earley, W. [4 ]
Szamosi, J. [5 ]
Eriksson, H. [5 ]
机构：
[1] Univ London, Imperial Coll Sch Med, London, England
[2] Quintiles CNS Therapeut, San Diego, CA USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] AstraZeneca, Wilmington, DE USA
[5] AstraZeneca R&D, Sodertalje, Sweden
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A randomised, placebo-controlled study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 332 - 333
  • [2] Efficacy of extended release Quetiapine Fumarate (Quetiapine XR) in patients with severe Major Depressive Disorder (MDD)
    Svedater, H.
    Thase, M.
    Locklear, J.
    Datto, C.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 43 - 44
  • [3] Extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S259 - S260
  • [4] POOLED ANALYSIS OF ADJUNCTIVE EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    El-Khalili, N.
    Bauer, M.
    Datto, C.
    Earley, W.
    Astrom, M.
    Eriksson, H.
    [J]. EUROPEAN PSYCHIATRY, 2009, 24
  • [5] EVALUATION OF POTENTIAL PREDICTORS OF RESPONSE TO TREATMENT WITH ADJUNCT EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MDD
    Bauer, M.
    Thase, M.
    Liu, S.
    Earley, W.
    Eriksson, H.
    [J]. EUROPEAN PSYCHIATRY, 2012, 27
  • [6] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study
    Bortnick, Brian
    El-Khalili, Nizar
    Banov, Michael
    Adson, David
    Datto, Catherine
    Raines, Shane
    Earley, Willie
    Eriksson, Hans
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (1-2) : 83 - 94
  • [7] Extended release Quetiapine Fumarate (Quetiapine XR) in acute and maintenance studies in Major Depressive Disorder (MDD): suicidality data
    Weisler, R.
    Montgomery, S. A.
    Eriksson, H. A.
    Szamosi, J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 45 - 46
  • [8] Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies
    Stein, Dan J.
    Bandelow, Borwin
    Merideth, Charles
    Olausson, Bengt
    Szamosi, Johan
    Eriksson, Hans
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 614 - 628
  • [9] Once-daily extended release quetiapine fumarate (quetiapine xr): Pooled safety data from 3 placebo-controlled monotherapy studies in acute schizophrenia
    Meulien, D.
    Brecher, M.
    Huizar, K.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S132 - S132
  • [10] Results from a phase III study of extended release quetiapine fumarate (quetiapine XR) as add-on to antidepressants in patients with major depressive disorder (MDD)
    Bauer, M.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 315 - 316
12345